Group One Trading’s Fortress Biotech FBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $115K | Sell |
37,700
-140,300
| -79% | -$362K | ﹤0.01% | 4738 |
|
|
2026
Q1 | $497K | Buy |
178,000
+10,800
| +6% | +$36.7K | ﹤0.01% | 3354 |
|
|
2025
Q4 | $612K | Sell |
167,200
-112,800
| -40% | -$321K | ﹤0.01% | 3307 |
|
|
2025
Q3 | $1.03M | Buy |
280,000
+229,500
| +454% | +$580K | ﹤0.01% | 2999 |
|
|
2025
Q2 | $93.9K | Buy |
50,500
+39,100
| +343% | +$67.7K | ﹤0.01% | 5022 |
|
|
2025
Q1 | $17.8K | Buy |
11,400
+6,900
| +153% | +$12.2K | ﹤0.01% | 5899 |
|
|
2024
Q4 | $9.11K | Buy |
4,500
+3,600
| +400% | +$6.52K | ﹤0.01% | 6146 |
|
|
2024
Q3 | $1.3K | Buy |
900
+500
| +125% | +$952 | ﹤0.01% | 6246 |
|
|
2024
Q2 | $684 | Hold |
400
| – | – | ﹤0.01% | 6420 |
|
|
2024
Q1 | $800 | Buy |
+400
| New | +$796 | ﹤0.01% | 6680 |
|
|
2021
Q3 | – | Sell |
-467
| Closed | -$25K | – | 8337 |
|
|
2021
Q2 | $25K | Buy |
+467
| New | +$28.2K | ﹤0.01% | 7051 |
|
|
2018
Q3 | – | Sell |
-1,013
| Closed | -$45K | – | 5308 |
|
|
2018
Q2 | $45K | Hold |
1,013
| – | – | ﹤0.01% | 4005 |
|
|
2018
Q1 | $69K | Buy |
1,013
+720
| +246% | +$45.6K | ﹤0.01% | 3483 |
|
|
2017
Q4 | $18K | Sell |
293
-207
| -41% | -$12.2K | ﹤0.01% | 4182 |
|
|
2017
Q3 | $33K | Sell |
500
-807
| -62% | -$54.4K | ﹤0.01% | 3834 |
|
|
2017
Q2 | $93K | Buy |
1,307
+1,287
| +6,435% | +$76K | ﹤0.01% | 3159 |
|
|
2017
Q1 | $1K | Buy |
+20
| New | +$895 | ﹤0.01% | 4496 |
|
|
2016
Q4 | – | Sell |
-1,333
| Closed | -$59K | – | 4522 |
|
|
2016
Q3 | $59K | Buy |
+1,333
| New | +$56.7K | ﹤0.01% | 3256 |
|
|
2015
Q2 | – | Sell |
-227
| Closed | -$13K | – | 4931 |
|
|
2015
Q1 | $13K | Sell |
227
-1,353
| -86% | -$56.4K | ﹤0.01% | 4057 |
|
|
2014
Q4 | $58K | Buy |
1,580
+827
| +110% | +$24.4K | ﹤0.01% | 3269 |
|
|
2014
Q3 | $24K | Sell |
753
-10,967
| -94% | -$291K | ﹤0.01% | 4011 |
|
|
2014
Q2 | $302K | Sell |
11,720
-5,913
| -34% | -$156K | ﹤0.01% | 2047 |
|
|
2014
Q1 | $524K | Buy |
17,633
+10,466
| +146% | +$408K | 0.01% | 1603 |
|
|
2013
Q4 | $283K | Buy |
7,167
+334
| +5% | +$12.9K | ﹤0.01% | 2130 |
|
|
2013
Q3 | $720K | Buy |
6,833
+6,313
| +1,214% | +$774K | 0.01% | 1283 |
|
|
2013
Q2 | $67K | Buy |
+520
| New | +$76.7K | ﹤0.01% | 3166 |
|
Other funds holding FBIO
OM
GCP
SAM
BCM
Group One Trading's FBIO Position: Q1 2026 in Review
Group One Trading sold out of Fortress Biotech (FBIO) in Q1 2026, closing a stake of 63,692 shares — an estimated $216K sold.
Group One Trading first reported a position in FBIO in Q2 2013 and held it in 25 quarters. The position peaked at $311K in Q2 2013. 52 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.
- Group One Trading reported no remaining Fortress Biotech position as of Q1 2026 after selling out during the quarter.
- Group One Trading sold 63,692 Fortress Biotech shares in Q1 2026, an estimated $216K.
- Group One Trading first reported a position in Fortress Biotech in Q2 2013 and held it in 25 quarters.
- Group One Trading's Fortress Biotech position peaked at $311K in Q2 2013.
- 52 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.